Jordan Elm to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications Jordan Elm has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.145
-
The impact of depressive symptoms in early Parkinson disease. Neurology. 2007 Jul 24; 69(4):342-7.
Score: 0.073
-
Exploratory analysis of glyburide as a novel therapy for preventing brain swelling. Neurocrit Care. 2014 Aug; 21(1):43-51.
Score: 0.030
-
An overview of the adaptive designs accelerating promising trials into treatments (ADAPT-IT) project. Ann Emerg Med. 2012 Oct; 60(4):451-7.
Score: 0.025
-
Optimizing the ongoing search for new treatments for Parkinson disease: using futility designs. Neurology. 2006 Mar 14; 66(5):628-33.
Score: 0.017